Morissa Jean Cohen, MD
Pediatrics · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cohen’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C199834 · Current
Licensed to practise in California · since 2024 · expires 2027-01-31 · Baylor College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$12,614 in 2024
Medicaid paid $12,614 for 276 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 56 | $5,775 |
| Return visit (30+ min) | 36 | $5,254 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $840 |
| Bilateral quantitative screening test of visual acuity | 78 | $295 |
| Screening test, pure tone, air only | 69 | $250 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 13 | $104 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 12 | $96 |
| 2024 | 276 | 7 | 21 | $12,614 |
| 2023 | 790 | 17 | 31 | $27,217 |
| 2022 | 396 | 8 | 27 | $18,098 |
| 2021 | 889 | 17 | 29 | $38,479 |
| 2020 | 730 | 14 | 41 | $33,603 |
| 2019 | 820 | 13 | 40 | $42,855 |
| 2018 | 961 | 13 | 47 | $50,698 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 60 | $8,675 |
| Short return visit (20+ min) | 83 | $7,338 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 49 | $2,710 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 29 | $1,890 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 12 | $1,860 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 13 | $1,356 |
| Bilateral quantitative screening test of visual acuity | 164 | $625 |
| Screening test, pure tone, air only | 148 | $492 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 60 | $472 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $422 |
| Hemoglobin A1C level | 22 | $355 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 41 | $304 |
2022
| Return visit (30+ min) | 48 | $6,952 |
| Short return visit (20+ min) | 56 | $5,552 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 94 | $4,445 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 50 | $336 |
| Bilateral quantitative screening test of visual acuity | 55 | $230 |
| Screening test, pure tone, air only | 53 | $220 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 28 | $208 |
| Hemoglobin A1C level | 12 | $156 |
2021
| Return visit (30+ min) | 113 | $16,263 |
| Short return visit (20+ min) | 154 | $13,849 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 39 | $2,450 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 17 | $1,120 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 14 | $980 |
| Bilateral quantitative screening test of visual acuity | 169 | $830 |
| Screening test, pure tone, air only | 152 | $725 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 16 | $698 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 68 | $528 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 14 | $200 |
| Measurement of lead | 12 | $185 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 43 | $170 |
2020
| Short return visit (20+ min) | 218 | $15,865 |
| Return visit (30+ min) | 75 | $9,157 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 56 | $3,360 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 52 | $2,660 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 15 | $915 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 70 | $552 |
| Bilateral quantitative screening test of visual acuity | 56 | $270 |
| Screening test, pure tone, air only | 55 | $255 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 32 | $168 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 32 | $168 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 13 | $96 |
| Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument | 13 | $81 |
2019
| Return visit (30+ min) | 134 | $19,452 |
| Short return visit (20+ min) | 135 | $14,017 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 30 | $2,100 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 13 | $2,015 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 16 | $1,469 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 17 | $1,120 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 122 | $960 |
| Bilateral quantitative screening test of visual acuity | 140 | $660 |
| Screening test, pure tone, air only | 118 | $525 |
| Measurement of lead | 12 | $185 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 53 | $170 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 18 | $144 |
2018
| Short return visit (20+ min) | 198 | $20,444 |
| Return visit (30+ min) | 140 | $18,976 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 54 | $3,500 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 32 | $2,030 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $1,356 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 28 | $1,330 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 149 | $1,176 |
| Measurement of lead | 44 | $622 |
| Bilateral quantitative screening test of visual acuity | 119 | $525 |
| Screening test, pure tone, air only | 88 | $385 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 52 | $164 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 13 | $104 |
Money from drug and device companies
$33 in 2019
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | None | $33 | 1 payment
|
See the published payment
| Novartis Pharmaceuticals | Meals · 2019-10-27 | None | $33 |
Professional record
- NPI
- 1376599621
- Licence
- CA C199834, OH 35077337California C199834: Current · expires 2027-01-31
More record details
- Sole proprietor
- No
- Medicaid ID
- OH 2216506
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-05-26
- NPI last updated
- 2025-01-31
- NPI record certified
- 2025-01-31
This is when the NPI record was last certified, not a medical board exam.